Rodent models of obesity/diabetes demonstrated significantly elevated serum levels of chemerin; exogenous chemerin administration further exacerbated glucose intolerance (Ernst et al., 2010). The gene discussed is RARRES2; the disease is obesity due to melanocortin 4 receptor deficiency.